Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company also provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane full-power x-ray system, including c-arm, powered table, motorized boom, and large high-definition monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. Stereotaxis, Inc. markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was incorporated in 1990 and is headquartered in Saint Louis, Missouri.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [05/08/2025 07:16 PDT] sector Stocks Expected To Be Up After Top Correlated Stocks Fire Buy Signals.
• [04/28/2025 08:00 PDT] STXS Expected to Trade Down After Bearish Patterns Develop
• [04/23/2025 10:29 PDT] Stereotaxis, Inc. (OTC:STXS), Up By 100% ($1.82) From $1.82 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [04/22/2025 07:26 PDT] STXS Expected to Trade Up After Bullish Patterns Develop
• [04/10/2025 07:42 PDT] sector Stocks Expected To Be Down After Top Correlated Stocks Fire Sell Signals.
• [04/10/2025 07:37 PDT] STXS Expected to Trade Down After Bearish Patterns Develop
• [04/07/2025 08:02 PDT] STXS Expected to Trade Down After Bearish Patterns Develop
• [03/31/2025 10:29 PDT] Stereotaxis, Inc. (OTC:STXS), Down By 100% ($1.95) From $1.95 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [03/27/2025 13:58 PDT] Stereotaxis, Inc. (OTC:STXS), Down By 100% ($2.14) From $2.14 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [03/25/2025 07:08 PDT] STXS Expected to Trade Down After Bearish Patterns Develop
• [03/20/2025 10:30 PDT] Stereotaxis, Inc. (OTC:STXS), Up By 100% ($1.95) From $1.95 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [03/20/2025 07:05 PDT] sector Stocks Expected To Be Down After Top Correlated Stocks Fire Sell Signals.
• [03/19/2025 16:11 PDT] Stereotaxis, Inc. (OTC:STXS), Up By 100% ($1.87) From $1.87 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [03/18/2025 07:18 PDT] STXS Expected to Trade Up After Bullish Patterns Develop
• [03/11/2025 07:21 PDT] STXS, Expected to Trade Higher After Bullish Insider Trading
• [03/10/2025 07:53 PDT] STXS Expected to Trade Up After Bullish Patterns Develop